Cutting-edge weight-loss drugs like Ozempic/Wegovy can cut alcohol intake dramatically in a short amount of time, a new study says. People taking semaglutide or liraglutide reduced their alcohol consumption by two-thirds within four months, according to results recently published in the journal Diabetes, Obesity and Metabolism. These glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone,… read on > read on >
Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says. Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading inside a person’s body. Now, a new analysis shows that people taking NRTI pills have as much as… read on > read on >
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across the U.S. who were overweight or obese and had another weight-related health problem.… read on > read on >
Women now have a new way to check their risk for cervical cancer — from the comfort of their own home. The U.S. Food and Drug Administration (FDA) has approved the Teal Wand, an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers, CBS News reported May 9. … read on > read on >
Why does sugar taste so good — and why do we want it so badly? Scientists may finally have the answer. For the first time, researchers have figured out the structure of the sweet receptor — the tiny part of your tongue that tells your brain when something tastes sweet. The study, published May 7… read on > read on >
Approvals align with agency’s goal of phasing out petroleum-based dyes in the national food supply read on >
The U.S. Food and Drug Administration (FDA) is warning consumers and tattoo artists that two tattoo inks have tested positive for harmful bacteria and could lead to serious infections. The affected products are: Sacred Tattoo Ink, Raven Black (CI# 77266; Lot#: RB0624, Best Before: June 28, 2027) Sacred Tattoo Ink, Sunny Daze (CI# 21095; Lot#:… read on > read on >
Childhood obesity nearly triples a person’s risk for experiencing discrimination or stigma based on their weight, a new study says. Severe obesity before age 18 increased a person’s odds of experiencing weight stigma by 2.8 times, researchers reported recently in the International Journal of Obesity. Weight stigma is marked by negative or discriminatory actions related… read on > read on >
A new drug combo lowers “bad” LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing one, ezetimibe. In a Phase 3 clinical trial, this combo reduced LDL levels by nearly 49% over about three months, according to Cleveland Clinic researchers. … read on > read on >
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research. The division oversees vaccines and biologic medicines, including gene therapies, CNN reported. Prasad is a hematologist-oncologist, a specialist in treating cancers of the blood. He has… read on > read on >
